Drugs / lurtotecan liposome
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00010179 | Oct 2000 → Oct 2002 | fallopian tube cancer, ovarian carcinoma, peritoneum cancer | NCIC Clinical Trials Group | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lurtotecan liposome | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00010179 ↗ |
| Route | Intravenous | “lurtotecan liposome IV over 30 minutes” NCT00010179 ↗ |